About: From SARS to COVID-19: What lessons have we learned?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: From SARS to COVID-19: What lessons have we learned? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	From SARS to COVID-19: What lessons have we learned?
Creator	Wang, Xiang Liu, Qin Wang, Wang, Wenmei Xu, Kaiyuan
Source	Elsevier; PMC
abstract	Abstract After the outbreak of severe acute respiratory syndrome (SARS) in November 2002, coronaviruses (CoVs) received worldwide attention. On December 1, 2019, the first case of coronavirus disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), was reported in Wuhan, China, and CoVs returned to public view. On December 30, 2019, the World Health Organization (WHO) declared that the COVID-19 epidemic is a public health emergency of international concern (PHEIC), and on March 11, 2020, the WHO classified COVID-19 as a pandemic disease. As of July 31, 2020, COVID-19 has affected 216 countries and regions, with 17,064,064 confirmed cases and 668,073 deaths, and the number of new cases has been increasing daily. Additionally, on March 19, 2020, there were no new confirmed cases in China, providing hope and valuable experience for the international community. In this review, we systematically compare COVID-19 and SARS in terms of epidemiology, pathogenesis and clinical characteristics and discuss the current treatment approaches, scientific advancements and Chinese experience in fighting the epidemic to combat the novel coronavirus pandemic. We also discuss the lessons that we have learned from COVID-19 and SARS.
has issue date	2020-08-21(xsd:dateTime)
bibo:doi	10.1016/j.jiph.2020.08.001
has license	els-covid
sha1sum (hex)	1c85654e988a5d97013e3ea5efca70ed44e61619
schema:url	https://doi.org/10.1016/j.jiph.2020.08.001
resource representing a document's title	From SARS to COVID-19: What lessons have we learned?
has PubMed Central identifier	PMC7442131
schema:publication	J Infect Public Health
resource representing a document's body	covid:1c85654e988a5d97013e3ea5efca70ed44e61619#body_text
is schema:about of	named entity 'outbreak' named entity 'Background' named entity 'received' named entity 'After' named entity 'Wuhan' named entity 'coronaviruses' named entity 'severe acute respiratory syndrome' named entity 'SARS' named entity 'coronaviruses' named entity 'COVID' named entity 'SARS' named entity 'coronaviruses' named entity 'virus' named entity 'SARS-CoV-2' named entity 'anti-inflammatory' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'organ dysfunction' named entity 'supportive treatment' named entity 'fatigue' named entity 'COVID-19 pandemic' named entity 'cardiovascular disease' named entity 'FDA' named entity 'hydroxychloroquine' named entity 'acute phase' named entity 'Digital media' named entity 'Lancet Respiratory Medicine' named entity 'oral cavity' named entity 'immune function' named entity 'NGS' named entity 'chloroquine phosphate' named entity 'angiotensin converting enzyme' named entity 'symptom' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'clinical data' named entity 'LDH' named entity 'SARS-CoV-2' named entity 'grows exponentially' named entity 'Nature Medicine' named entity 'Severe respiratory failure' named entity 'headache' named entity 'long time' named entity 'global pandemic' named entity 'receptor' named entity 'highly contagious' named entity 'genome' named entity 'pneumonia' named entity 'SARS' named entity 'lymphocyte' named entity 'SARS-CoV-2' named entity 'aerosol' named entity 'WHO' named entity 'bat' named entity 'oxygen therapy' named entity 'fever' named entity 'CoV' named entity 'epidemic' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'ventilator support' named entity 'organ' named entity 'SARS-CoV' named entity 'chest CT' named entity 'MERS' named entity 'behavior patterns' named entity 'nucleotide sequences' named entity 'epidemiology' named entity 'growth phase' named entity 'China' named entity 'older patients' named entity 'SARS-CoV' named entity 'Michael Osterholm' named entity 'pharyngeal' named entity 'COVID-19' named entity 'viruses' named entity 'ACE2' named entity 'biopsy' named entity 'China'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software